Our discovery described here that the E46K α-synuclein point mutation is specifically permissive for DLB α-synuclein prion replication coupled with our earlier finding that E46K prevented MSA α-synuclein prion propagation (16, 18) offers diagnostic and possibly therapeutic opportunities. This evidence concerns the gene SNCA and Lewy body dementia.